Health Care and Biotech
Alcidion’s IT Targets Hospital Efficiency
Alcidion is an emerging operator in the field of hospital IT, with technology that can reduce deaths attributable to medical error. The stock price has doubled since it listed on ASX in February this year.
Dec 19 2016
Estia Health Beset By Uncertainty
Estia Health is beset by uncertainty surrounding the sustainability of earnings and this is not expected to moderate in the near term.
Dec 13 2016
Rebound For Sirtex
Michael Gable of Fairmont Equities suggests technically, Sirtex Medical should be set to recover.
Dec 13 2016
Sirtex Reaction Overdone
Increased competition has wedged dose sales for Sirtex Medical but brokers suspect the market’s reaction is overdone.
Dec 12 2016
Previous Stories
Has Cochlear Selling Run Its Course?
Nov 19 2013
Michael Gable of Fairmont Equities notes the technicals are suggesting Cochlear may be oversold at this level, suggesting potential upside.
Competition Batters Cochlear
Nov 06 2013
The competitors are ganging up on Cochlear from several directions and brokers fear the company does not have the arsenal to fight them off easily.
Temporary Softness For ResMed
Oct 29 2013
ResMed’s first quarter update provided a window on the competitive bidding process in the US. Brokers were relieved the headwinds seem to be abating.
Weekly Broker Wrap: Insurance, Health Care, Advertising And Gaming
Oct 18 2013
Competition heats up in Oz insurance, Oz health care players in the US market, the advertising story continues and the outlook for slot machines in the US.
Cochlear Confidence Falls On Deaf Ears
Oct 16 2013
Brokers are toughening their stance on Cochlear after the company delivered guidance for no profit growth in FY14.
Celldex Therapeutics – Too Late For Ted
Oct 11 2013
Life sciences sector analyst Stuart Roberts reports Celldex Therapeutics (Nasdaq: CLDX) is in Phase III with a cancer vaccine which can double median overall survival for glioblastoma patients.
Oz Health Care Providers On A Solid Footing
Oct 02 2013
The latest Medicare data shows pathology and diagnostic services are growing firmly. Macquarie finds the sector has few concerns.
Brokers Positive On Sonic’s Latest Acquisition
Sep 30 2013
Sonic Healthcare will acquire five laboratories in Germany and brokers find the expansion has a lot of merit.
Lines On The Face Of Health Sector
Sep 23 2013
Healthcare stocks have been robust performers in a defensive environment but brokers now see other sectors pushing to the fore.
Weekly Broker Wrap: Aust Healthcare, Building, Retail, Gaming And Transport
Sep 06 2013
The outlook for Aust healthcare stocks is attractive, building and retail are mixed while gaming and transport are subdued.
Analyse The Market From A Different Angle
Latest News
| 1 |
Next Week At A Glance – 27-31 Jan 20254:17 PM - Weekly Reports |
| 2 |
Chrysos Corp’s Road Paved With Gold11:30 AM - Small Caps |
| 3 |
Weekly Top Ten News Stories – 24 January 202511:00 AM - Weekly Reports |
| 4 |
In Case You Missed It – BC Extra Upgrades & Downgrades – 24-01-2510:54 AM - Weekly Reports |
| 5 |
Insurers To Pamper Shareholders With Buybacks10:00 AM - Australia |